Ausgabe 8/2020
Inhalt (24 Artikel)
Up Front
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature
Prasad Katulanda, Harsha A. Dissanayake, Ishara Ranathunga, Vithiya Ratnasamy, Piyumi S. A. Wijewickrama, Nilukshana Yogendranathan, Kavinga K. K. Gamage, Nipun L. de Silva, Manilka Sumanatilleke, Noel P. Somasundaram, David R. Matthews
Exercising your fat (metabolism) into shape: a muscle-centred view
Anne Gemmink, Patrick Schrauwen, Matthijs K. C. Hesselink
The competitive athlete with type 1 diabetes
Michael C. Riddell, Sam N. Scott, Paul A. Fournier, Sheri R. Colberg, Ian W. Gallen, Othmar Moser, Christoph Stettler, Jane E. Yardley, Dessi P. Zaharieva, Peter Adolfsson, Richard M. Bracken
Train like an athlete: applying exercise interventions to manage type 2 diabetes
Mladen Savikj, Juleen R. Zierath
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Abdallah Al-Salameh, Ingrid Allix, Coralie Amadou, Gwénaëlle Arnault, Florence Baudoux, Bernard Bauduceau, Sophie Borot, Muriel Bourgeon-Ghittori, Olivier Bourron, David Boutoille, France Cazenave-Roblot, Claude Chaumeil, Emmanuel Cosson, Sandrine Coudol, Patrice Darmon, Emmanuel Disse, Amélie Ducet-Boiffard, Bénédicte Gaborit, Michael Joubert, Véronique Kerlan, Bruno Laviolle, Lucien Marchand, Laurent Meyer, Louis Potier, Gaëtan Prevost, Jean-Pierre Riveline, René Robert, Pierre-Jean Saulnier, Ariane Sultan, Jean-François Thébaut, Charles Thivolet, Blandine Tramunt, Camille Vatier, Ronan Roussel, Jean-François Gautier, Pierre Gourdy
Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
Jack A. Sargeant, Emer M. Brady, Francesco Zaccardi, Frances Tippins, David R. Webb, Vanita R. Aroda, Edward W. Gregg, Kamlesh Khunti, Melanie J. Davies
Pregnancy loss is associated with type 2 diabetes: a nationwide case–control study
Pia Egerup, Anders P. Mikkelsen, Astrid Marie Kolte, David Westergaard, Steen Rasmussen, Filip K. Knop, Øjvind Lidegaard, Henriette S. Nielsen
Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents
Valentino Cherubini, Julia M. Grimsmann, Karin Åkesson, Niels H. Birkebæk, Ondrej Cinek, Klemen Dovč, Rosaria Gesuita, John W. Gregory, Ragnar Hanas, Sabine E. Hofer, Reinhard W. Holl, Craig Jefferies, Geir Joner, Bruce R. King, Elizabeth J. Mayer-Davis, Alexia S. Peña, Birgit Rami-Merhar, Ulrike Schierloh, Torild Skrivarhaug, Zdenek Sumnik, Jannet Svensson, Justin T. Warner, Nataša Bratina, Dana Dabelea
Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes
Alison K. Wright, Paul Welsh, Jason M. R. Gill, Evangelos Kontopantelis, Richard Emsley, Iain Buchan, Darren M. Ashcroft, Martin K. Rutter, Naveed Sattar
Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: a bi-directional Mendelian randomisation study
Jie V. Zhao, C. Mary Schooling
Islet pericytes convert into profibrotic myofibroblasts in a mouse model of islet vascular fibrosis
Luciana Mateus Gonçalves, Elizabeth Pereira, João Pedro Werneck de Castro, Ernesto Bernal-Mizrachi, Joana Almaça
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes
Kameron B. Rodrigues, Matthew J. Dufort, Alba Llibre, Cate Speake, M. Jubayer Rahman, Vincent Bondet, Juan Quiel, Peter S. Linsley, Carla J. Greenbaum, Darragh Duffy, Kristin V. Tarbell
Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice
Yasumasa Ikeda, Hiroaki Watanabe, Tetsuya Shiuchi, Hirofumi Hamano, Yuya Horinouchi, Masaki Imanishi, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya, Toshiaki Tamaki
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity
Anastasia Kalinovich, Nodi Dehvari, Alice Åslund, Sten van Beek, Carina Halleskog, Jessica Olsen, Elisabete Forsberg, Evelyn Zacharewicz, Gert Schaart, Mia Rinde, Anna Sandström, Roger Berlin, Claes-Göran Östenson, Joris Hoeks, Tore Bengtsson
Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults
Mi-Hyang Jung, Sang-Wook Yi, Sang Joon An, Beverley Balkau, Jee-Jeon Yi, Hyeongsu Kim
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
Joseph E. O’Reilly, Luke A. K. Blackbourn, Thomas M. Caparrotta, Anita Jeyam, Brian Kennon, Graham P. Leese, Robert S. Lindsay, Rory J. McCrimmon, Stuart J. McGurnaghan, Paul M. McKeigue, John A. McKnight, John R. Petrie, Sam Philip, Naveed Sattar, Sarah H. Wild, Helen M. Colhoun
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
Katie Harris, Megumi Oshima, Naveed Sattar, Peter Würtz, Min Jun, Paul Welsh, Pavel Hamet, Stephen Harrap, Neil Poulter, John Chalmers, Mark Woodward
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study
Jeroen H. P. M. van der Velde, Annemarie Koster, Elsa S. Strotmeyer, Werner H. Mess, Danny Hilkman, Jos P. H. Reulen, Coen D. A. Stehouwer, Ronald M. A. Henry, Miranda T. Schram, Carla J. H. van der Kallen, Casper G. Schalkwijk, Hans H. C. M. Savelberg, Nicolaas C. Schaper
Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea
Shigeru Suzuki, Tokuo Mukai, Takahide Kokumai, Akiko Furuya, Yusuke Tanahashi, Hiroshi Azuma
Diabetic retinopathy: looking beyond the eyes
Rafael Simó, Coen D. A. Stehouwer, Angelo Avogaro
Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?
Anette-Gabriele Ziegler, Ezio Bonifacio
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)
John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A. D’Alessio, Melanie J. Davies